These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 16028002)
1. Positron Emission Tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal. Trautmann TG; Zuger JH Mol Imaging Biol; 2005; 7(4):309-13. PubMed ID: 16028002 [TBL] [Abstract][Full Text] [Related]
2. Role of positron emission tomography-computed tomography in the management of anal cancer. Mistrangelo M; Pelosi E; Bellò M; Ricardi U; Milanesi E; Cassoni P; Baccega M; Filippini C; Racca P; Lesca A; Munoz FH; Fora G; Skanjeti A; Cravero F; Morino M Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):66-72. PubMed ID: 22592047 [TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer. Bannas P; Weber C; Adam G; Frenzel T; Derlin T; Mester J; Klutmann S Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):445-51. PubMed ID: 20832181 [TBL] [Abstract][Full Text] [Related]
4. FDG-PET/CT in the evaluation of anal carcinoma. Cotter SE; Grigsby PW; Siegel BA; Dehdashti F; Malyapa RS; Fleshman JW; Birnbaum EH; Wang X; Abbey E; Tan B; Kodner IJ; Hunt SR; Lowney JK; Mutch MG; Dietz DW; Myerson RJ Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):720-5. PubMed ID: 16626889 [TBL] [Abstract][Full Text] [Related]
5. The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer. Winton Ed; Heriot AG; Ng M; Hicks RJ; Hogg A; Milner A; Leong T; Fay M; MacKay J; Drummond E; Ngan SY Br J Cancer; 2009 Mar; 100(5):693-700. PubMed ID: 19259091 [TBL] [Abstract][Full Text] [Related]
6. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer. Mistrangelo M; Pelosi E; Bellò M; Castellano I; Cassoni P; Ricardi U; Munoz F; Racca P; Contu V; Beltramo G; Morino M; Mussa A Int J Radiat Oncol Biol Phys; 2010 May; 77(1):73-8. PubMed ID: 19632066 [TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography/computed tomography in the staging and treatment of anal cancer. Sveistrup J; Loft A; Berthelsen AK; Henriksen BM; Nielsen MB; Engelholm SA Int J Radiat Oncol Biol Phys; 2012 May; 83(1):134-41. PubMed ID: 22000745 [TBL] [Abstract][Full Text] [Related]
8. Role of Houard C; Pinaquy JB; Mesguich C; Henriques de Figueiredo B; Cazeau AL; Allard JB; Laharie H; Bordenave L; Fernandez P; Vendrely V J Nucl Med; 2017 Sep; 58(9):1414-1420. PubMed ID: 28280225 [TBL] [Abstract][Full Text] [Related]
9. Posttreatment FDG-PET-CT response is predictive of tumor progression and survival in anal carcinoma. Goldman KE; White EC; Rao AR; Kaptein JS; Lien WW Pract Radiat Oncol; 2016; 6(5):e149-e154. PubMed ID: 26948134 [TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
12. Endoanal ultrasound in the staging and management of squamous-cell carcinoma of the anal canal: potential implications of a new ultrasound staging system. Tarantino D; Bernstein MA Dis Colon Rectum; 2002 Jan; 45(1):16-22. PubMed ID: 11786758 [TBL] [Abstract][Full Text] [Related]
13. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794 [TBL] [Abstract][Full Text] [Related]
14. Metabolic tumour volume of anal carcinoma on (18)FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival. Mohammadkhani Shali S; Schmitt V; Behrendt FF; Winz OH; Heinzel A; Mottaghy FM; Eble MJ; Verburg FA Eur J Radiol; 2016 Aug; 85(8):1390-4. PubMed ID: 27423677 [TBL] [Abstract][Full Text] [Related]
15. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound. Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870 [TBL] [Abstract][Full Text] [Related]
16. Negative 18F-FDG-PET-CT may exclude residual or recurrent disease in anal cancer. Teagle AR; Gilbert DC; Jones JR; Burkill GJ; McKinna F; Dizdarevic S Nucl Med Commun; 2016 Oct; 37(10):1038-45. PubMed ID: 27341410 [TBL] [Abstract][Full Text] [Related]
17. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer. Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451 [TBL] [Abstract][Full Text] [Related]
18. Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography. Roedl JB; Harisinghani MG; Colen RR; Fischman AJ; Blake MA; Mathisen DJ; Mueller PR Ann Thorac Surg; 2008 Oct; 86(4):1131-8. PubMed ID: 18805147 [TBL] [Abstract][Full Text] [Related]
19. PET-CT fusion in radiation management of patients with anorectal tumors. Anderson C; Koshy M; Staley C; Esiashvili N; Ghavidel S; Fowler Z; Fox T; Esteves F; Landry J; Godette K Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):155-62. PubMed ID: 17707268 [TBL] [Abstract][Full Text] [Related]
20. Impact of PET/CT on initial staging, restaging and treatment management of anal cancer: a clinical case with literature review. Piperkova E; Raphael B; Altinyay M; Castellon I; Libes R; Sandella N; Abdel-Dayem H J BUON; 2006; 11(4):523-7. PubMed ID: 17309188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]